Primary Device ID | 03573026628154 |
NIH Device Record Key | 62511d60-12f8-417e-bf01-1c8d3e47ef0e |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | VITEK® MS knowledge base v3.3 |
Version Model Number | 3.3 |
Company DUNS | 276816717 |
Company Name | BIOMERIEUX SA |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | false |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | false |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 03573026628154 [Primary] |
PEX | System, Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | New |
Device Record Status | Published |
Public Version Number | 1 |
Public Version Date | 2023-11-22 |
Device Publish Date | 2023-11-14 |
03573026626891 - VIDAS® TBI (GFAP, UCH-L1) | 2024-11-08 VIDAS TBI (GFAP, UCH-L1) is an automated quantitative test to be used on VIDAS3. It is intended to be used as an aid in the eval |
03573026359096 - VITEK® MS-DS | 2024-04-30 The VITEK MS-DS target slides enable the identification of microorganisms according to the MALDI-TOF mass spectrometry method. |
03573026359119 - VITEK® MS | 2024-04-29 MALDI-Tof Mass Spectrometry system used for microbial identification |
03573026362843 - VITEK® MS FA | 2024-04-29 VITEK ® MS - FA is used to pretreat yeasts to facilitate their identification according to the MALDI - TOF method. It is used e |
03573026619527 - VIDAS® PC SOFTWARE V4.9 | 2024-04-29 VIDAS PC V4.9 W10 Software version for clinic |
03573026256685 - ETEST® Gentamicin (GM) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026376604 - ETEST® Amoxicillin (AC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1 |
03573026377731 - ETEST® Flucytosine (FC) | 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VITEK 87490229 5531511 Live/Registered |
bioMerieux Inc. 2017-06-15 |
VITEK 86243079 not registered Dead/Abandoned |
MENDEZ, LUIS ANTONIO MONTANA 2014-04-04 |
VITEK 79239620 not registered Live/Pending |
OOO "Business-Aliance" 2018-06-22 |
VITEK 79043404 3705393 Dead/Cancelled |
OOO "Business-Aliance" 2007-03-06 |
VITEK 79002691 not registered Dead/Abandoned |
OOO "Business-Aliance" 2004-05-17 |
VITEK 78539879 not registered Dead/Abandoned |
Vitek MD. Ph.D., Jiri 2004-12-29 |
VITEK 78458972 not registered Dead/Abandoned |
Eric M. Meckes 2004-07-29 |
VITEK 78219204 not registered Dead/Abandoned |
Meckes, Eric M. 2003-02-26 |
VITEK 78064372 not registered Dead/Abandoned |
International Trade Distributors, Inc. 2001-05-18 |
VITEK 77765610 3820520 Live/Registered |
VITEK INDUSTRIAL PRODUCTS, INC. 2009-06-22 |
VITEK 77531903 4362649 Live/Registered |
bioMérieux, Inc. 2008-07-25 |
VITEK 75252806 not registered Dead/Abandoned |
bioMerieux Vitek, Inc. 1997-03-06 |